• National Cancer Institute
  • National Human Genome Research Institute

FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma Are Sensitive to Inhibition by Targeted Therapies - Rachel Liao, TCGA Scientific Symposium 2012

You will need Adobe Flash Player 8 or later and JavaScript enabled to view this video.


FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma Are Sensitive to Inhibition by Targeted Therapies - Rachel Liao, TCGA Scientific Symposium 2012




 >> View All Videos